08:08 AM EST, 11/06/2024 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Q3 net income Wednesday of $544 million, up from $72 million a year earlier.

Comparable analysts' estimates were not available.

Total income and other revenue for the quarter ended Sept. 30 was $565 million, up from $536 million a year earlier.

Three analysts polled by Capital IQ expected $731.8 million.

As of Sept. 30, the company said it had $950 million in cash and cash equivalents.

Royalty Pharma ( RPRX ) shares were up 3.1% in recent Wednesday premarket activity.

Price: 27.94, Change: +0.84, Percent Change: +3.10